ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Lung Cancer - Staging

March 18, 2020
The authors examined the SEER database to assess racial disparities in use of PET for lung cancer staging 2007-2015 and subsequent one-year survival. Blacks  (OR 0.54) and Hispanics (OR 0.72) were less likely to undergo PET compared to non-Hispanic whites. Use of PET was associated with improved survival (HR 0.61).  
August 21, 2019
An interesting discussion in this manuscript of a case-control study of 666 subjects.
August 20, 2019
Interesting follow-up study of 208 pulmonary ground -glass opacities in 160 subjects, with a yield of three adenocardinomas.
May 20, 2019
Rates of unforeseen N2 disease were similar between nodal staging by EBUS and mediastinoscopy, but mediastinoscopy had a complication rate of 6%.
April 17, 2019
Dr Burt gives a brief overview of the considerable advances for patients with thoracic malignancies (non–small cell lung cancer in particular).
September 26, 2018
Data in the STS Database indicate that invasive mediastinal staging is underused in patients undergoing resection for non-small cell lung cancer, and that the pattern of use varies widely among the participants. Use of guidelines outlining indications for invasive mediastinal staging should be encouraged.
May 4, 2018
Patient Care and General Interest An article in the New York Times looks at the ethical dilemma of performing surgery for endocarditis in illicit drug users whose addictions go untreated.
April 13, 2018
The authors demonstrate that mediastinoscopy at the time of either open or VATS lobectomy is independently associated with an increased risk of postoperative pulmonary complications (OR 1.46 and 1.53, respectively).
February 1, 2018
Decaluwé and colleagues prospectively tested the capacity of preoperative staging by video-assisted mediastinoscopy (VAM) or VAM-lymphadenectomy (VAM-LA) to detect hidden mediastinal lymph node involvement in patients with non-small cell lung cancer (NSCLC).

Pages